Universitaetsklinikum Schleswig-Holstein AöR

The Dermatologie department at Universitaetsklinikum Schleswig-Holstein AöR in Kiel is active in research on skin and connective tissue diseases and broader immune system diseases. Much of the work focuses on common chronic inflammatory conditions such as atopic dermatitis, psoriasis, hidradenitis suppurativa, bullous pemphigoid, and prurigo nodularis, with trials aimed at testing new therapies and improving long-term disease control.

• Atopic dermatitis, psoriasis, and hidradenitis suppurativa research centered on better symptom control and durable treatment responses
• Bullous pemphigoid studies evaluating newer immune-targeted treatment options for this rare blistering disorder
• Prurigo nodularis and related itch-driven skin conditions focused on relieving chronic discomfort and improving quality of life
• Vitiligo and cutaneous lupus erythematosus trials exploring immune-based approaches for inflammatory skin disease

Overall, the site supports a strong dermatology portfolio that combines inflammation, autoimmunity, and itch-related skin disorders in studies designed to refine treatment effectiveness and long-term safety.

Another major research focus is digestive system disease, especially Crohn’s disease and ulcerative colitis. These trials examine whether newer targeted and immune-modulating treatments can improve remission, bowel healing, and day-to-day disease control for people living with chronic inflammatory bowel disease.

• Crohn’s disease studies aimed at reducing inflammation and achieving deeper intestinal healing
• Ulcerative colitis trials assessing better control of active disease and sustained remission
• Fistulizing perianal Crohn’s disease research addressing one of the more complex forms of inflammatory bowel disease
• Transmural healing and disease-modifying approaches that look beyond symptom relief alone

At Universitaetsklinikum Schleswig-Holstein AöR, this area reflects a clear interest in improving both the effectiveness and the long-term impact of treatment for chronic gastrointestinal inflammation.

The site has a substantial portfolio in hemic and lymphatic diseases, with many studies in acute myeloid leukemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple forms of lymphoma. Research also extends to stem cell transplantation and graft-versus-host disease, reflecting a strong interest in improving outcomes for patients with blood cancers and transplant-related complications.

• Acute myeloid leukemia and acute lymphoblastic leukemia trials exploring more effective treatment strategies for newly diagnosed and relapsed disease
• Chronic lymphocytic leukemia, small lymphocytic lymphoma, and mantle cell lymphoma studies focused on better disease control and deeper remission
• Multiple myeloma and other B-cell malignancies research evaluating newer immune and targeted therapies
• Allogeneic hematopoietic stem cell transplantation and graft-versus-host disease studies aimed at improving transplant safety and recovery

This is one of the most active research areas at the site, combining oncology, immunology, and cell therapy to advance care for complex hematologic diseases.

Clinical research in neoplasms and broader oncology covers a wide range of cancers, including breast cancer, melanoma, lung cancer, ovarian cancer, head and neck cancer, endometrial cancer, and urothelial carcinoma. These studies are generally designed to test new treatment combinations, improve survival, or reduce the risk of recurrence after standard therapy.

• Breast cancer research spanning early-stage, locally advanced, and metastatic disease
• Melanoma and cutaneous squamous cell carcinoma trials focused on advanced skin cancers and recurrence prevention
• Lung cancer, pleural mesothelioma, and head and neck cancer studies evaluating treatment effectiveness in difficult-to-treat tumors
• Ovarian cancer, endometrial cancer, and urothelial carcinoma research aimed at improving outcomes in advanced disease

The oncology program at Universitaetsklinikum Schleswig-Holstein AöR shows broad activity across both common and rare cancers, with a strong emphasis on better disease control and longer survival.

The trial portfolio also includes important work in cardiovascular diseases, nervous system diseases, and immune-mediated disorders. Research topics include heart failure, stroke, hypertension, Alzheimer’s disease, epilepsy, multiple sclerosis, and systemic autoimmune conditions such as rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis.

• Heart failure, aortic stenosis, and broader cardiovascular disease studies focused on improving outcomes and reducing complications
• Acute ischemic stroke and transient ischemic attack research aimed at preventing disability and recurrent events
• Epilepsy, multiple sclerosis, and Alzheimer’s disease trials exploring better symptom management and disease modification
• Autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis assessing new immune-targeted treatments

These studies highlight the site’s wider research reach beyond dermatology, with a focus on chronic diseases where better control, safety, and quality of life remain central goals.